Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
46°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adicet Bio Inc
(NQ:
ACET
)
1.600
+0.030 (+1.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adicet Bio Inc
< Previous
1
2
3
4
5
6
7
Next >
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
January 04, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook
January 03, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
December 29, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
December 10, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Wedbush Maintains Outperform Rating for Adicet Bio: Here's What You Need To Know
November 09, 2023
Via
Benzinga
6 Analysts Have This to Say About Adicet Bio
June 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 08, 2023
Via
Benzinga
Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio's Innovative Approach
November 27, 2023
Why Are Gamma-Delta T Cells Important In Fighting Cancer?
Via
Benzinga
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 08, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference
November 07, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting
November 02, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
October 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference
October 04, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 29, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
September 27, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 09, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Announces Appointment of Katie Peng to the Board of Directors
July 11, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 30, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Analyst Downgrades Adicet Citing Uncertainty, Awaits Long-Term Data On Durability
June 27, 2023
JMP Securities downgraded Adicet Bio Inc (NASDAQ: ACET) to a Market Perform (from Market Outperform) and removed the
Via
Benzinga
Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results
June 27, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42....
Via
Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 27, 2023
Via
Benzinga
Dow Up Triple Digits As Consumer Confidence Increases
June 27, 2023
Stocks are on the rise this afternoon.
Via
Talk Markets
Dow Surges Over 100 Points; Walgreens Lowers Earnings Forecast
June 27, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.39% to 33,845.82 while the NASDAQ rose 0.55% to 13,408.91. The S&P 500,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023
June 27, 2023
Via
Benzinga
US Stocks Higher; Durable Goods Orders Top Estimates
June 27, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 75 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.19% to 33,780.40 while the NASDAQ rose...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 27, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.